1. Townsend, N, Wilson, L, Bhatnagar, P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016; 1–14.
Google Scholar | Medline2. Klein, L, Grau-Sepulveda, MV, Bonow, RO, et al. Quality of care and outcomes in women hospitalized for heart failure Circ Heart Fail 2011; 4: 589–598.
Google Scholar | Crossref | Medline | ISI3. Scardovi, AB, Petruzzi, M, Rosano, A, et al. Heart failure phenotype in women. G Ital Cardiol (Rome) 2012; 13: 6S–11S.
Google Scholar | Medline4. Crousillat, DR, Ibrahim, NE. Sex differences in the management of advanced heart failure. Curr Treat Options Cardiovasc Med 2018; 20: 88.
Google Scholar | Crossref | Medline5. Garcia, M, Mulvagh, SL, Bairey Merz, CN, et al. Cardiovascular disease in women: clinical perspectives. Circ Res 2016; 118: 1273–1293.
Google Scholar | Crossref | Medline | ISI6. Galvao, M, Kalman, J, DeMarco, T, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Cardiac Fail 2006; 12: 100–107.
Google Scholar | Crossref | Medline | ISI7. Passino, C, Aimo, A, Emdin, M, et al. Quality of life and outcome in heart failure with preserved ejection fraction: when sex matters. Int J Cardiol 2018; 267: 141–142.
Google Scholar | Crossref | Medline8. Providência, R, Marijon, E, Lambiase, PD, et al. Primary prevention implantable cardioverter defibrillator (ICD) therapy in women – data from a multicenter French registry. J Am Heart Assoc 2016; 5: e002756.
Google Scholar | Crossref | Medline9. Han, Z, Chen, Z, Lan, R, et al. Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy. PLoS One 2017; 12: e0180513.
Google Scholar | Medline10. Morris, AA, Cole, RT, Laskar, SR, et al. Improved outcomes for women on the heart transplant wait list in the modern era. J Cardiac Fail 2015; 21: 555–560.
Google Scholar | Crossref | Medline11. Sciomer, S, De Carlo, C, Moscucci, F, et al. Age at menopause: a fundamental data of interest to acquire in female patients’ anamnesis. Int J Cardiol 2016; 215: 358–359.
Google Scholar | Crossref | Medline12. Levy, WC, Mozaffarian, D, Linker, DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006; 113: 1424–1433.
Google Scholar | Crossref | Medline | ISI13. Lund, LH, Aaronson, KD, Mancini, DM. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol 2005; 95: 734–741.
Google Scholar | Crossref | Medline | ISI14. Sartipy, U, Dahlström, U, Edner, M, et al. Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry. Eur J Heart Fail 2014; 16: 173–179.
Google Scholar | Crossref | Medline | ISI15. Agostoni, P, Corrà, U, Cattadori, G, et al.; MECKI Score Research Group . Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710–2718.
Google Scholar | Crossref | Medline | ISI16. Arena, R, Myers, J, Aslam, SS, et al. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 2004; 147: 354–360.
Google Scholar | Crossref | Medline | ISI17. Corrà, U, Agostoni, P, Giordano, A, et al.; MECKI Score Research Group . Sex profile and risk assessment with cardiopulmonary exercise testing in heart failure: propensity score matching for sex selection bias. Can J Cardiol 2016; 32: 754–759.
Google Scholar | Crossref | Medline18. Salvioni, E, Corrà, U, Piepoli, M, et al.; MECKI score research group . Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction. ESC Heart Fail 2020; 7: 371–380.
Google Scholar | Medline19. Carubelli, V, Metra, M, Corrà, U, et al.; MECKI score research group. Exercise performance is a prognostic indicator in elderly patients with chronic heart failure – application of metabolic exercise cardiac kidney indexes score Circ J 2015; 79: 2608–2615.
Google Scholar | Crossref | Medline20. Lavie, CJ, Milani, RV, Ventura, HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925–1932.
Google Scholar | Crossref | Medline | ISI21. Zafrir, B, Salman, N, Crespo-Leiro, MG, et al. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology [published correction appears in Eur J Heart Fail. 2017 Mar;19(3):437]. Eur J Heart Fail 2016; 18: 859–868.
Google Scholar | Crossref | Medline22. Kenchaiah, S, Evans, JC, Levy, D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–313.
Google Scholar | Crossref | Medline | ISI23. Kenchaiah, S, Pocock, SJ, Wang, D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 116: 627–636.
Google Scholar | Crossref | Medline | ISI24. Ebong, IA, Goff, DC, Rodriguez, CJ, et al. Mechanisms of heart failure in obesity. Obes Res Clin Pract 2014; 8: e540–e548. DOI: 10.1016/j.orcp.2013.12.005
Google Scholar | Crossref | Medline | ISI25. Horwich, TB, Fonarow, GC, Hamilton, MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789–795.
Google Scholar | Crossref | Medline | ISI26. Clark, AL, Fonarow, GC, Horwich, TB. Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol 2015; 115: 209–213.
Google Scholar | Crossref | Medline27. Zamora, E, Lupón, J, Enjuanes, C, et al. No benefit from the obesity paradox for diabetic patients with heart failure. Eur J Heart Fail 2016; 18: 851–858.
Google Scholar | Crossref | Medline28. Van Iterson, EH, Kim, CH, Uithoven, K, et al. Obesity and hemoglobin content impact peak oxygen uptake in human heart failure. Eur J Prev Cardiol 2018; 25: 1937–1946.
Google Scholar | SAGE Journals | ISI29. Piepoli, MF, Corrà, U, Veglia, F, et al.; MECKI Score Research Group . Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group. Eur J Heart Fail 2016; 18: 545–553.
Google Scholar | Crossref | Medline | ISI